Frequently Asked Questions

Back to Top

What is Rett syndrome?

Rett syndrome is a unique developmental disorder which begins to show its effects in infancy or early childhood. It is seen almost exclusively in girls, although it can occur rarely in boys. It is found in all racial and ethnic groups throughout the world.

Back to Top

What causes Rett syndrome?

Rett syndrome is caused by a mutation in the MECP2 gene on the X chromosome. The MECP2 gene is responsible for turning other genes off and on (some genes are active for only a specific period in development and then shut off forever.) MECP2 mutations (change in the gene) cause the turn-on-off mechanism to fail, allowing other genes to stay active when they are no longer needed, or not come on when they are needed.

Back to Top

She seemed to develop so normally.
What happened?

Rett syndrome results from a chain of events beginning with the MECP2 genetic mutation. Mutations occur naturally in everyone all the time and most do not cause problems. The MECP2 mutation results in a shortage or absence of MeCP2 protein needed to direct other genes. These downstream genes produce proteins or factors which control the normal development of special regions of the brain responsible for sensory, emotional, motor and autonomic function. Development appears to be normal in early infancy until these factors that are required for further brain development need to be active or inactive. Without these factors, selected regions of the brain remain developmentally immature. This explains why the child appears to be developing normally in the first months of life.

Back to Top

If it is a genetic, does this mean I may have another child with Rett?

The chance of having more than one child with RS is very small, less than one percent. This means that more than 99% of the time, the mutation is sporadic, just occurs on its own and is not repeated in a family.

Back to Top

At what age does Rett syndrome begin?

The age when Rett syndrome begins and the severity of different symptoms may vary. The child with Rett is usually born healthy and shows an early period of apparently normal or near normal development until 6–18 months of life, when there is a slowing down or stagnation of skills. A period of regression then follows when she loses communication skills and purposeful use of her hands. Soon, stereotyped hand movements, gait disturbances, and slowing of the normal rate of head growth become apparent. Other problems may include seizures and disorganized breathing patterns which occur when she is awake. There may be a period of isolation or withdrawal when she is irritable and cries inconsolably. (I might add a little more hope here) Around school age, interaction and attention tend to improve and other symptoms may decrease or improve although motor performance may slow.

Back to Top

What kind of handicaps will she have?

Apraxia (dyspraxia), the inability to program the body to perform motor movements, is the most fundamental and severely handicapping aspect of Rett syndrome. It can interfere with every body movement, including eye gaze and speech, making it difficult for the girl with Rett to do what she wants to do. Due to this apraxia and her inability to speak, it is very difficult to make an accurate assessment of her intelligence. Most traditional testing methods require her to use her hands and/or speech, which may be impossible. Her mobility may be delayed and she may have difficulty crawling or walking.

Back to Top

Since she loses skills, is Rett syndrome degenerative?

Rett syndrome is not a degenerative disorder, but it is a developmental disorder. Barring illness or complications, survival into adulthood is expected.

Back to Top

How often does Rett syndrome occur?

While many health professionals may not be familiar with RS, it is a relatively frequent cause of delayed development in girls. The prevalence rate in various countries is from 1:10,000 to 1:23,000 live female births, making it three times more common in females than phenylketonuria (PKU), a congenital error of metabolism for which every newborn in the USA is tested. The incidence rate is about 1:10,000 female births. However, Rett syndrome has most often been misdiagnosed as autism, cerebral palsy or non–specific developmental delay.

Back to Top

How is Rett syndrome diagnosed?

The diagnosis of Rett syndrome is made on the basis of the fulfillment of the diagnostic criteria. The presence of the MECP2 mutation (a blood test) confirms the diagnosis. Most mutations are sporadic, and occur only once in a family. There are more than 200 mutations in the MECP2 gene which contribute to Rett syndrome. Most of these are found in eight hotspots in the coding region of the gene (part of the gene which makes the MeCP2 protein). Mutations have been found in more than 95% of girls who fulfill the diagnostic criteria for RS. For the remaining 5% who do not currently show a MECP2 mutation, yet do still fulfill the diagnostic criteria, it is felt that their mutations are located in a part of the very large MECP2 gene not yet screened. So, at this time, it is possible to have Rett syndrome with or without the MECP2 mutation. Because researchers now understand that the MECP2 mutation also causes other disorders, it is possible to have the MECP2 gene mutation and not have Rett syndrome.

Back to Top

What disorders must be ruled out?

Other possible conditions which could look like Rett syndrome must be ruled out. They include Angelman syndrome (would remove this; it is out of favor Happy Puppet Syndrome) and Prader–Willi syndrome (not too likely to confuse with RS), metabolic disorders of the urea cycles such as Ornithine transcarbamylase deficiency) deficiency and of organic acids and amino acids; storage diseases such as Batten disease, and mitochondrial disorders. While there are no scientific tests for them, autism and cerebral palsy are often misdiagnosed as Rett syndrome.

Back to Top

How does Rett syndrome differ from autism?

Mutations in the MECP2 gene are found in Rett syndrome and have also been identified in some girls with autism, so they are branches of the same tree. While Rett occurs primarily in girls, autism occurs much more frequently in boys. In both conditions, there is loss of speech and emotional contact. However, features seen in Rett and not in autism include deceleration of the rate of head growth and loss of purposeful hand skills and mobility. While hand flapping is seen frequently in autism, the wider range of compulsive purposeless hand stereotypies common to Rett are not seen in autism. The girl with Rett almost always prefers people to objects, but the opposite is seen in autism. Unlike those with autism, the girl with Rett syndrome often enjoys affection. While girls with Rett syndrome often have autistic tendencies at an early age, these features decrease over time.

Back to Top

How is the Rett diagnosis made?

The first step should be for your child’s doctor to look carefully at her early growth and development and evaluate her medical history and physical and neurological status. In making the diagnosis, specialists rely on a RS Diagnostic Criteria Worksheet, which has been developed by the world’s foremost authorities in Rett syndrome. After the clinical diagnosis is made or suspected, the next step is to get the MECP2 blood test.

Back to Top

Your daughter may fall into one of three clinical categories:

  • Classic RS: those who meet the diagnostic criteria guidelines;
  • Provisional RS : age 1–3, with some clinical evidence of RS, but not enough to meet the diagnostic criteria;
  • Atypical RS : those who do not meet all of the diagnostic criteria for classical RS. The diagnosis of atypical RS must include at least three of the primary criteria and five of the supportive criteria. Atypical cases account for about 15 percent of the total of diagnosed cases.

Types of atypical RS include:

  • Congenital Onset: developmental delay is noticed shortly after birth; no early normal development occurs; or seizures begin before the regression period. IS THIS STILL CONSIDERERD OR ARE THESE CDKL5? Still considered. CDKL5 is not composed solely of these early onset types either. Only a subset.
  • Late Onset: signs are delayed beyond the typical 18 month onset, in some cases to 10 years.
  • Preserved Speech and Hand Skills: milder, incomplete symptoms are seen, with age of onset often delayed up to 3 to 4 years
  • Males: boys may not conform to the same symptoms seen in girls. Most of the very few boys with the MECP2 mutation have a more debilitating condition than girls, and thus are not often recognized.

Back to Top

What are the diagnostic criteria for Rett syndrome? How can I be sure my daughter has it?

Most parents know their daughters better than anyone. Often, they know that Rett syndrome fits from the first description. Physicians use the following Diagnostic Criteria Guidelines:

Necessary criteria (must be present for the diagnosis)

  1. apparently normal prenatal and perinatal history
  2. psychomotor development largely normal through the first six months or may be delayed from birth
  3. normal head circumference at birth
  4. postnatal deceleration of head growth in the majority of patients
    loss of achieved purposeful hand skill between ages six months and 2.5 years
  5. stereotypic hand movements such as hand wringing/squeezing, clapping/tapping, mouthing and washing/rubbing automatisms
  6. emerging social withdrawal, communication dysfunction, loss of learned words, and cognitive impairment
  7. impaired (dyspraxic) or failing locomotion

Supportive criteria (not necessary for the diagnosis, but may also be seen)

  1. awake disturbances of breathing (hyperventilation, breath-holding, forced expulsion of air or saliva, air swallowing)
  2. teeth grinding (bruxism)
  3. impaired sleep pattern from early infancy
  4. abnormal muscle tone successively associated with muscle wasting and dystonia
  5. peripheral vasomotor disturbances (cold, blue hands and feet)
  6. scoliosis/kyphosis progressing through childhood
  7. growth retardation
  8. hypotrophic (small) feet; small, thin hands

Exclusion criteria (rule out the diagnosis)

  1. enlarged organs or other signs of storage disease
  2. retinopathy, optic atrophy, or cataract
  3. evidence of brain damage before or after birth
  4. existence of identifiable metabolic or other progressive neurological disorder
  5. acquired neurological disorder resulting from severe infection or head trauma

Back to Top

Is Rett syndrome seen predominantly in one race?

No. A statewide population study in Texas has revealed that the incidence of RS in the African–American and Hispanic population in the United States is comparable to that in Caucasian Americans.

Back to Top

What are the stages of Rett syndrome?

The stages for Rett syndrome were developed by Prof. Bengt Hagberg and colleagues prior to the identification of mutations in MECP2. At present, they are not widely used by physicians in this country.

Stage I
Early Onset Stage
Age: 6 months to 1.5 years
Duration: Months

Stage II
Rapid Destructive Stage
Age: 1 to 4 years
Duration: Weeks to Months

Stage III
Plateau Stage
Age: Preschool to school years
Duration: Years

Stage IV
Late Motor Deterioration Stage
Age: When stage III ceases, 5-25+ years
Duration: Up to decades

For more information about the stages of Rett syndrome http://www.rettsyndrome.org/main/stages.htm

Back to Top

Do all girls move through the stages of Rett syndrome similarly?

No. The stages of Rett syndrome are simply provided to help understand the natural history of the disorder. The course of Rett syndrome is predetermined according to her mutation and X-inactivation status as well as other yet to be determined factors, and varies from one child to another, including the age when Rett begins and the speed and severity of symptoms. Therefore, two girls of the same age can appear quite different.

Back to Top

Can the severity be predicted?

Just as in any other disorder, there can be a wide range of disability ranging from mild to severe. It is difficult to predict the intensity of symptoms in any individual child. Many girls begin walking within the normal range, while others show significant delay or inability to walk independently. Some begin walking and lose this skill, while others continue to walk throughout life. Still others do not walk until late childhood or adolescence. The same patterns hold true for using her hands and other skills she may acquire.

Back to Top

What will she be able to do?

Although the girl with Rett syndrome will need help for most activities of daily living, she can learn some independent skills. Most girls can learn to use the toilet and many can learn to feed themselves by hand or with utensils with some assistance. Some girls can learn to use augmentative devices to communicate. Despite their difficulties, girls and women with Rett can continue to learn and enjoy family and friends well into middle age and beyond. They experience a full range of emotions and show their engaging personalities as they take part in social, educational and recreational activities at home and in the community.

Back to Top

What drugs have been tried?

  • L–Dopa is a component in the pathway for the production of dopamine. It has been found to improve rigidity during the motor deterioration stage (4), but otherwise failed to provide improvement on a consistent basis.
  • Naltrexone (Revia) is an opiate antagonist, used to alleviate the drug high in addicts. It was tried in RS due to the unusually high level of naturally–occurring opium–like brain chemicals called endorphins in the spinal fluid of girls with RS, and their diminished response to pain. The study was limited to the dose of 1 mg/kg/day and did not show dramatic results. However, independent studies have shown that use of naltrexone in higher or lower doses may be beneficial in controlling irregular breathing and seizures, and in alleviating screaming spells. This may be due to the drug’s sedative effects. One negative aspect of the study was that performance on the Bayley Scales of Infant Development was significantly worse during the administration of the drug compared to placebo, also possibly due to its sedative effect. Another negative side effect is loss of appetite.
  • Bromocriptine (Parlodel) is a drug which improves the functioning of the dopamine system in the brain. One drug trial showed initial improvements in communication, decreased agitation and reduced hand movements in the first phase; however, when the drug was stopped symptoms reappeared, and the reintroduction of the drug did not bring back the initial improvements. The drug was found to be most effective in those girls who had milder symptoms.
  • Tyrosine (dopamine and noradrenalin precursor) and Tryptophan (serotonin precursor) are amino acids, used to boost neurotransmitter levels. The study indicated no differences in clinical performance or EEG patterns.
  • L–Carnitine is a derivative of the essential amino acid lysine, and is often found to be deficient in those who take anticonvulsants. A single case report of one child indicated improvements in language and awareness. However, the child reported was an atypical case of RS, and these results have not been replicated. In another study of 35 girls, carnitine supplements (100 mg/kg/day) did not lead to any major neurological improvements in the group as a whole. However, approximately 75% of the families involved in the study reported subtle, but important improvements to their quality of life while on the drug, including increased alertness, increased mobility, less daytime sleeping, increased energy, and improvement in constipation. Some parents reported their daughter saying a word for the first time in a number of years. L–carnitine has been found beneficial in a large group of girls with RS to increase muscle mass. A beneficial side effect is loose stools.
  • The Blue Bird Circle Rett Center at Baylor College of Medicine, Houston, Texas and the Rett Center for Excellence at the University of Alabama at Birmingham completed a double-blind placebo-controlled treatment study using betaine and folate. Participants were stratified by age (less than 5 and equal to or greater than 5) and were required to have a MECP2 mutation. Using several objective measures, no improvement was noted among those taking folate and betaine. However, by parents’ assessment using a subjective scale of features typically seen in Rett syndrome, participants in the young group taking folate and betaine had significantly better responses based on this questionnaire, especially for attention, interaction, and mood. Some of the older participants were also noted to have similar improvements, but as a group the overall results did not achieve statistical significance. A paper describing this study and its results is currently being reviewed for publication.
  • A clinical drug trial using dextromethorphan (DM) has been initiated at the Children’s Center in Johns Hopkins Hospital. It has been shown that receptors for the excitatory amino acids glutamate, in particular the NMDA type, are increased in the brain of young girls with RS. This neurotransmitter and its receptors, when in excess, cause harmful over-stimulation of the nerve cells (neurons) in the brain, contributing in part to the seizures, behavioral phenotype, and cognitive impairment, in RS. The study will examine the effects of this neurotransmitter and its excessive receptors using DM because of its identified ability to block NMDA receptor channels. This drug is available for human consumption. Infants with respiratory infections and cough, as well as non-ketotic hyperglycinemia are treated with DM, and it has been well tolerated. The clinical trial will study the benefits of DM vs. placebo on EEG, seizures, cognition, and motor impairment seen in RS.

 

Back to Top

What is life expectancy?

Due to the rarity of Rett syndrome, very little is known about long term prognosis and life expectancy. Most of those who have been identified are under 18 years of age. It is often difficult to identify older girls and women due to the frequent lack of complete infant and childhood developmental records. However, studies have determined that a girl with Rett has a 95% chance of surviving to age 20–25 years. This compares to a 98% survival probability for the general U.S. female population. Between the ages of 25–40, the survival rate drops to 69% in Rett, compared to 97% in the general U.S. female population. The average life expectancy of a girl given the diagnosis of RS may exceed 50 years. New data from the IRSA-supported North American database indicate that 50% survival may extend beyond 50 years. (manuscript in preparation). While these statistics show that life expectancy is less in Rett, it is not nearly as low as other similar neurological disorders.

Back to Top

What are the causes of death?

It is important to note that only 7% of cases reported to the IRSA have resulted in death. This means that 93% of those diagnosed are still living. The most frequently reported causes of death (one–quarter of deaths) are variations of sudden, unexplained death with no apparent underlying cause such as an acute injury or infection. The factors most strongly associated with an increased risk of sudden unexplained death in RS are uncontrolled seizures, swallowing difficulties and lack of mobility. Neither physical nor occupational therapy, nutritional status, and living arrangements made a difference in the incidence of sudden unexplained death. Ongoing studies should help predict which girls are at greatest risk and which girls might benefit most from new medical or educational interventions. Other deaths have resulted from pneumonia. The factors most strongly associated with an increased risk of death by pneumonia are compromised lung function due to scoliosis and difficulty swallowing. Other causes of death include malnutrition, intestinal perforation or twisted bowel, as well as accidents and illness. Girls with Rett syndrome are as likely as any child to have the common pediatric disorders such as cystic fibrosis or diabetes mellitus.

Back to Top

When she dies, what can we do to help find answers?

Although she may be at higher risk for life–threatening events such as pneumonia, choking and seizures, it is very likely that your daughter will live a long life. However, we are all at risk for accidents of many types and illnesses that are unexpected. A time will come when we will all die. Researchers are ready to listen, to learn, and to share. You can participate in research studies and post-mortem examinations that will help us understand Rett syndrome.

Back to Top

What has research taught us about RS?

Studies have revealed that although the brain of an individual with Rett syndrome is 30% smaller than normal, there are no obvious malformations, gross abnormalities or signs of infection. There is increased neuronal cell packing density. That is, cells should be further apart, but in RS they are very close together because cell–to–cell connections are not well–developed along the route. Neurons are reduced in size and there is reduced branching, which interferes with functions such as thinking, doing, and feeling. The number of synapses (brain–cell to brain–cell connections) is about half the normal number. Abnormalities in multiple areas of the brain may account for the following clinical symptoms:

  • Frontal lobe: Cerebral blood flow appears reduced, particularly in frontal brain regions. This looks like what might be seen in a 7 week-old child. This area is much more involved than other brain parts. It is necessary for mood and emotion.
  • Caudate: much smaller than normal; involved in cognition, awareness and behavior
  • Putamen: no anatomical change; necessary for movement
  • Temporal lobe (limbic system): no anatomical change; needed for memory, learning, emotion, behavior.
  • Cerebellum: reduction in some cell populations; needed for equilibrium and balance.
  • Hippocampus: no anatomical change; necessary for information processing.
  • Substantia Nigra: marked reduction in the pigment, melanin, and degeneration of cells; necessary for movement and critical thinking
  • Medulla (Brain stem): strong evidence of brain stem immaturity, leading to problems with the autonomic nervous system, such as sleep, salivation, breathing, heart rate, swallowing, bowel motility, blood circulation in hands and feet, and reduced sensitivity to pain.
  • Neurotransmitters: reduced. These include: 1) Dopamine and serotonin - necessary for movement and critical thinking, 2) Acetylcholine - necessary for memory, cognition, movement control, and 3) Glutamate - necessary for brain plasticity, important in seizures and cell death.

Back to Top

What has research found?

Rett syndrome was previously described as a neurodegenerative disorder, with very poor prognosis and little potential for learning. Scientific studies have now identified Rett syndrome as a disorder of developmental arrest, which begins shortly before or after birth at a critical time of brain and synapse formation.

Back to Top

How do we know that RS is a condition of developmental arrest?

 Supportive Clinical Evidence

  • Early onset
  • Normal head size at birth
  • Low muscle tone
  • Weak cry and poor suck
  • Abnormal 4th toe (short)
  • Improved learning and gaining new skills, especially, beginning at school age

Supportive Neurobiological Evidence

  • Small brain (12–33% reduction)
  • No malformations, storage, demyelination, infection, gliosis, or evidence of progressive cell loss
  • Dendritic arborizations, cell differentiation and neuronal growth affected
  • Small neurons with increased neuronal packing, migration not affected
  • Thinning of hippocampus
  • Significant involvement of caudate nucleus
  • Decreased melanin (pigment) in substantia nigra
  • Lack of mature olfactory (smell) neurons

Supportive Immunochemical Evidence

  • Early cholinergic deficits result in abnormal dendritic differentiation
  • MAP 2 decreased or absent in inner layer of cortex

These studies reverse the previous hypothesis of brain degeneration, opening doors to educational programs and therapies that will help. Studies have raised speculation that the primary conduction abnormality may be influenced by neurotrophic (growth) factors responsible for maturation of the heart and central nervous system. It is felt that these same neurotrophic factors may drive changes in the intestinal tract. These studies pave the way for treatments that will ultimately lead to a better way of life for girls with rett syndrome and a method to prevent sudden, unexplained deaths.

Back to Top

What are the clinical research findings in Rett syndrome?

Autonomic Findings

  • Agitation
  • Dyspraxia
  • Slow responsiveness
  • Poor sensory–motor integration
  • Disorganized breathing
  • Vasomotor changes (blue hands and feet)
  • Vacant spells
  • Constipation 90%
  • Abdominal distention (bloating) 50%

Biochemical Findings

  • Transient elevation of plasma ammonia
  • Elevated levels of beta–endorphins
  • Decreasing levels of dopamine & norepinephrine with age in cerebrospinal fluid (CSF)
  • Transient elevation of lactic acid & alanine in plasma cerebrospinal fluid (CSF)

Cardiovascular Findings

  • Sudden unexplained death, 25% of all deaths (reported deaths 7% of total population)
  • Immaturity of the atrio–ventricular conduction system (heart)

Nutritional Findings

  • Growth failure has many causes, but has a strong basis in nutritional deficit.
  • Progressive weight and height failure unless aggressive nutritional rehabilitation is undertaken.
  • Repetitive involuntary motor movements are not associated with increased energy expenditure.
  • Sleeping metabolic rates are low and are consistent with features of malnutrition; these findings can be reversed with nutritional support
  • Deficits in lean body mass persist despite aggressive refeeding regimens.
  • Deficits in lean body mass may be associated with increased rates of amino acid oxidation and urea recycling.
  • Preliminary data suggest that the intestinal absorption of calcium and vitamin D status are normal in RS, despite the presence of reduced bone mineral density.
  • Oropharyngeal dysfunction and gastroesophageal dysmotility are found in 100% and 69% of Rett syndrome girls, respectively.
  • Abnormalities of oropharyngeal dysfunction include poor tongue mobility, reduced oropharyngeal clearance, and laryngeal penetration of liquid & solid food during swallowing.
  • Esophageal dysmotility, including abnormal wave patterns, delayed emptying, atony, gastroesophageal reflux; gastric dysmotility, including diminished gastric peristalsis or atony.

Neurophysiological Findings

  • Seizures are reportedly a common problem
  • Prolonged video/EEG/polygraphic studies confirm that the occurrence of epileptic seizures is overestimated in Rett syndrome. Many events were frequently reported as typical seizures but were not associated with EEG severe discharge; these events include twitching, head turning, staring, laughing, pupil dilatation, breath holding, and hyperventilation. Actual seizures may be under recognized.
  • No one characteristic seizure type has been identified in Rett syndrome; both focal and generalized electrographic seizures are recorded. Video/EEG monitoring may be necessary to provide definitive information regarding the need for anticonvulsant therapy.

Neuropathological Findings

  • Morphologic (anatomical) features are unique, with only decreased brain weight being consistently present. The brain is preferentially involved in this altered growth; other organ weights are appropriate for the individual’s height.
  • No consistent evidence of a degenerative, inflammatory or ischemic process.
  • No evidence of a progressive change in brain morphology over time. MRI and EEG studies support this observation.
  • Best hypothesis to fit the fact that there is no recognizable disease process is that RS seems to be the result of a maturational arrest of brain development. Golgi studies suggest that arrested brain development affects dendritic size in selected brain regions, namely the frontal, motor, and limbic regions. This change is not seen in Trisomy 21 (Down Syndrome.)
  • Alterations in numerous neurotransmitters have been observed, but there does not yet appear to be consistent data suggesting that the primary defect is in any of them.
  • Is mitochondrial disease a secondary effect in RS?
  • Morphologic research is directed towards identifying possible deficiencies in neurotrophic factors which could initiate the changes which appear to be an arrest of brain development.

 

Back to Top

Epidemiology And Survival

The prevalence of Rett syndrome is 1 per 22,800 (0.44/10000) females aged 2–18 years of age as determined in the Texas Rett Syndrome Registry. Incidence values are limited, varying from 0.43-0.71/10,000 females in France to 1.09/10,000 females in Australia.

Rett syndrome has been reported in all races and ethnic groups.

Rett individuals have an estimated 70% survival at age 35 years; this contrasts sharply with an estimated 27% survival at 35 years for severely retarded individuals.

The majority of deaths in Rett syndrome are either sudden and unexpected or secondary to pneumonia.